Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM

Sunandana Chandra, MD, MS, discusses safety and efficacy data from the IMCgp100-202 trial on tebentafusp, and comments on the clinical implications of these data.